Sort by
Refine Your Search
-
academia and practice regarding the cost-effectiveness analysis of safety instrumented systems. You will conduct cost-effectiveness analyses by designing cost models to highlight trade-offs in
-
“Handshake Complexes of Chiral Nanoparticles and Proteins” (CHIRAL-PRO ). The overarching goal of CHIRAL-PRO is to develop a widely applicable methodology to design chiral nanoparticles (NPs) with exceptional
-
systems by design with specific focus on the chemical industry and you contribute to attracting external funding. You will assist in the supervision of PhD students and other team members. You will publish
-
strategic use of political disinformation accusations across time and space, and contribute to high-impact publications. You will collaborate with other project members (PhDs, postdocs, principal and co
-
evaluation of FAPI-based radioligands, focusing on their imaging and therapeutic potential. Key tasks include: Designing, planning, and executing preclinical experiments in cell and animal models of cancer
-
applicable methodology to design chiral nanoparticles (NPs) with exceptional optical activity, for strong and predictable enantioselective interactions with nanoscale biological entities, such as proteins and
-
, focusing on their imaging and therapeutic potential. Key tasks include: Designing, planning, and executing preclinical experiments in cell and animal models of cancer. Conducting biodistribution, dosimetry
-
member's task is strongly intertwined with the tasks of the other team members. You will design, train and apply generative models that learn how to complete missing wedges in the reciprocal space of crystal
-
Parkinson’s biology. Supervise junior colleagues, contribute to grant writing, and disseminate findings through high-impact publications. Profile PhD in neuroscience, immunology, stem cell biology, or related
-
writing, and disseminate findings through high-impact publications. Profile PhD in neuroscience, immunology, stem cell biology, or related discipline. Proven expertise in Parkinson’s disease models and iPSC